AAAAAA

   
Results: 1-10 |
Results: 10
PHARMACOKINETICS OF PEG-HIRUDIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE
Authors: STEIN G BUCHA E POSCHEL K JANSA U SCHINDLER S ESSLINGER HU NOWAK G
Citation: G. Stein et al., PHARMACOKINETICS OF PEG-HIRUDIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 368-368
MONITORING OF THE ANTICOAGULANT EFFECTS OF PEG-HIRUDIN ADMINISTERED AS A CONTINUOUS 24-HOUR INFUSION FOLLOWING AN IV BOLUS INJECTION IN HEALTHY-VOLUNTEERS USING THE ECARIN CLOTTING TIME
Authors: ESSLINGER HU DUBBERS K RADZIWON P BREDDIN HK
Citation: Hu. Esslinger et al., MONITORING OF THE ANTICOAGULANT EFFECTS OF PEG-HIRUDIN ADMINISTERED AS A CONTINUOUS 24-HOUR INFUSION FOLLOWING AN IV BOLUS INJECTION IN HEALTHY-VOLUNTEERS USING THE ECARIN CLOTTING TIME, Thrombosis and haemostasis, 1997, pp. 1135-1135
MONITORING OF THE ANTICOAGULANT EFFECTS OF COMBINED (OVERLAPPING) TREATMENT OF PEG-HIRUDIN AND HEPARIN USING THE ECARIN CLOTTING TIME
Authors: ESSLINGER HU HUHLE G KESSLER M DUBBERS K MALSCH R PIAZOLO L HARENBERG J
Citation: Hu. Esslinger et al., MONITORING OF THE ANTICOAGULANT EFFECTS OF COMBINED (OVERLAPPING) TREATMENT OF PEG-HIRUDIN AND HEPARIN USING THE ECARIN CLOTTING TIME, Thrombosis and haemostasis, 1997, pp. 1138-1138
MONITORING OF THE ANTICOAGULANT EFFECTS OF A CONTINUOUS 6-HOUR INFUSION OF PEG-HIRUDIN IN HEALTHY-VOLUNTEERS USING THE ECARIN CLOTTING TIME
Authors: HAAS S DUBBERS K MAURER R ESSLINGER HU
Citation: S. Haas et al., MONITORING OF THE ANTICOAGULANT EFFECTS OF A CONTINUOUS 6-HOUR INFUSION OF PEG-HIRUDIN IN HEALTHY-VOLUNTEERS USING THE ECARIN CLOTTING TIME, Thrombosis and haemostasis, 1997, pp. 1142-1142
INFLUENCE OF THE COMBINATION OF PEG-HIRUDIN AND HEPARIN ON BLOOD-COAGULATION
Authors: GIESE C HARENBERG J MALSCH R HUHLE G PIAZOLO L ESSLINGER HU
Citation: C. Giese et al., INFLUENCE OF THE COMBINATION OF PEG-HIRUDIN AND HEPARIN ON BLOOD-COAGULATION, Thrombosis and haemostasis, 1997, pp. 1146-1146
INTERACTIONS OF COMBINED (OVERLAPPING) TREATMENT WITH PEG-HIRUDIN ANDHEPARIN IN HEALTHY-VOLUNTEERS
Authors: HARENBERG J HUHLE G KESSLER M MALSCH R PIAZOLO L DUBBERS K ESSLINGER HU
Citation: J. Harenberg et al., INTERACTIONS OF COMBINED (OVERLAPPING) TREATMENT WITH PEG-HIRUDIN ANDHEPARIN IN HEALTHY-VOLUNTEERS, Thrombosis and haemostasis, 1997, pp. 2008-2008
PHARMACODYNAMIC AND SAFETY RESULTS OF PEG-HIRUDIN IN HEALTHY-VOLUNTEERS
Authors: ESSLINGER HU HAAS S MAURER R LASSMANN A DUBBERS K MULLERPELTZER H
Citation: Hu. Esslinger et al., PHARMACODYNAMIC AND SAFETY RESULTS OF PEG-HIRUDIN IN HEALTHY-VOLUNTEERS, Thrombosis and haemostasis, 77(5), 1997, pp. 911-919
SUPERIOR PERFORMANCE OF ECARIN CLOTTING TIME OVER APTT FOR THE MONITORING OF PEG-HIRUDIN ACTIVITY IN PLASMA
Authors: HAAS S ESSLINGER HU RUBSAMEN K JESKE WP WALENGA JM
Citation: S. Haas et al., SUPERIOR PERFORMANCE OF ECARIN CLOTTING TIME OVER APTT FOR THE MONITORING OF PEG-HIRUDIN ACTIVITY IN PLASMA, Blood, 90(10), 1997, pp. 3225-3225
THROMBIN INHIBITION ENHANCES ASPIRIN-INDUCED BLEEDING-TIME PROLONGATION
Authors: BREDDIN HK RADZIWON P ESSLINGER HU
Citation: Hk. Breddin et al., THROMBIN INHIBITION ENHANCES ASPIRIN-INDUCED BLEEDING-TIME PROLONGATION, Circulation, 94(8), 1996, pp. 1561-1561
PHASE-I RESULTS ON PEG-HIRUDIN (LU-57291), A SAFE AND EFFECTIVE ANTICOAGULANT WITH PROLONGED ACTIVITY
Authors: ESSLINGER HU HAAS S LASSMANN A STEMBERGER A BAUMGARTNER M BLUMEL G MULLERPELTZER H
Citation: Hu. Esslinger et al., PHASE-I RESULTS ON PEG-HIRUDIN (LU-57291), A SAFE AND EFFECTIVE ANTICOAGULANT WITH PROLONGED ACTIVITY, Thrombosis and haemostasis, 73(6), 1995, pp. 1452-1452
Risultati: 1-10 |